Screener
Intellia Therapeutics NTLA Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $106.13M-32.0% | $134.7M+6.2% | $155.46M-17.8% | $193.39M+60.5% | $156.17M+19.4% | ||
| $331.63M+9.3% | $241.29M-36.0% | $294.42M-28.6% | $317.66M-40.9% | $303.48M-45.8% | ||
| $7.32M-35.5% | $9.13M-13.1% | $9.47M+11.2% | $11.05M+24.8% | $11.35M-7.9% | ||
| $527.83M+6.4% | $466.45M-15.4% | $527.71M-17.5% | $581.94M-18.1% | $495.95M-34.5% | ||
| $15.06M-34.0% | $15.52M-38.2% | $17.67M-35.5% | $20.42M-29.0% | $22.81M-24.7% | ||
| $857.16M-4.6% | $758.78M-23.1% | $842.13M-29.3% | $925.28M-21.1% | $898.89M-24.6% | ||
| $11.71M+19.5% | $18.8M+52.1% | $20.25M+38.8% | $13.26M+0.9% | $9.8M-47.9% | ||
| $0-100% | $630K-97.0% | $7.29M-64.7% | $12.25M-44.7% | $17.15M-22.7% | ||
| $79.39M-16.9% | $76.45M-32.1% | $103.88M-6.3% | $93.73M-11.3% | $95.5M-9.1% | ||
| $129.46M-29.5% | $137.84M-33.2% | $170.73M-46.5% | $176.85M-16.1% | $183.64M-16.7% | ||
| $14K+40.0% | $12K+20.0% | $12K+20.0% | $12K+20.0% | $10K0.0% | ||
| -$2.79B-16.7% | -$2.69B-17.2% | -$2.59B-19.0% | -$2.49B-21.8% | -$2.39B-25.1% | ||
| $727.71M+202% | $620.94M-20.4% | $671.39M-23.0% | $748.42M-22.3% | -$715.26M-174% | ||
| $857.16M-4.6% | $758.78M-23.1% | $842.13M-29.3% | $925.28M-21.1% | $898.89M-24.6% |
FAQ
- What are Intellia Therapeutics's total assets?
- Intellia Therapeutics (NTLA) holds $857.2M in total assets, down 4.6% year over year.
- How much debt does Intellia Therapeutics have?
- Intellia Therapeutics carries $73.4M in total debt against $727.7M of shareholders' equity, a debt-to-equity ratio of 0.10.
- How much cash does Intellia Therapeutics have?
- Intellia Therapeutics holds $106.1M in cash and equivalents.
- Can Intellia Therapeutics cover its short-term obligations?
- Its current ratio is 6.65 — current assets exceed current liabilities.
- Where does Intellia Therapeutics's balance sheet data come from?
- Every line is extracted from Intellia Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
